KO · Healthcare

ViGenCell Inc. (308080)

Biotechnology

ViGenCell Inc. (308080) is listed on KO in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported P/E ratio is 25.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 308080

P/E ratio

25.00

Gross profit (TTM)

$0

Net margin

0.0%

ViGenCell Inc. (308080) — FAQ

What is 308080's P/E ratio?

The price-to-earnings (P/E) ratio for ViGenCell Inc. (308080) is 25.00 (data as of 2026-05-21).

Does ViGenCell Inc. pay a dividend?

Dividend yield is not available in the current snapshot for ViGenCell Inc. (308080). Check the MyAverix Finance app for the latest dividend data.

What sector is ViGenCell Inc. in?

ViGenCell Inc. (308080) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 308080 listed on?

308080 is listed on KO.

What is ViGenCell Inc.'s net margin?

ViGenCell Inc. (308080) reports a net margin of 0.0% (data as of 2026-05-21).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)